XML 41 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Note 9 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   

2022

   

2021

 

Noncurrent deferred income tax asset arising from:

               
                 

Accounts payable

  $ 461,253     $ 272,585  

Property, plant, and equipment

    39,598       11,090  

Equity-based compensation

    112,336       65,127  

Contribution carryforward

    5,856       4,860  

NOL carryforward

    3,994,815       3,452,349  

NEL carryforward

    239,315       324,685  

R&D credit

    626,347       365,668  

Operating lease liability

    48,594       -  

Capitalized research and development expense

    1,639,623       -  

Total deferred tax assets

    7,167,737       4,496,364  
                 

Noncurrent deferred income tax liability arising from:

               

Trade receivables and prepaid expenses

    (374,517 )     (655,804 )

Operating lease ROU asset

    (48,171 )     -  

Total deferred income tax liabilities

    (422,688 )     (655,804 )
                 

Net noncurrent deferred income tax asset

    6,745,049       3,840,560  
                 

Valuation allowance

    (6,745,049 )     (3,840,560 )
                 

Net

  $ -     $ -  
Summary of Operating Loss Carryforwards [Table Text Block]
   

December 31,

 

Combined NOL Carryforwards:

 

2022

   

2021

 

Federal

  $ 19,022,927     $ 16,439,757  

State

  $ 9,836,072     $ 16,439,757  
Summary of Tax Credit Carryforwards [Table Text Block]
   

December 31,

 

Combined Credit Carryforwards:

 

2022

   

2021

 

Federal

  $ 626,347     $ 365,668  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
   

December 31,

 

Rate reconciliation:

 

2022

   

2021

 

Federal tax benefit at the statutory rate

    (21.0 )%     (21.0 )%

State tax, net of federal benefit

    (2.0 )%     (2.0 )%

Nondeductible expenses

    0.8 %     1.0 %

Other

    0.7 %     %

Life insurance

    %     5.0 %

Provision to return true up

    (0.6 )%     1.0 %

Research & development credits

    (2.2 )%     (4.0 )%

Change in the valuation allowance

    24.2 %     30.0 %

PPP loan forgiveness

    %     (10.0 )%

Income Tax Expense (Benefit)

    %     %